Silently Disciplining Research. “Freedom of Speech Is the Right to Scrutinize Power and Society” – Global Research

24-03-21 11:22:00,

All Global Research articles can be read in 27 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).


Researchers who question the legitimacy of US wars, seem to experience being ousted from their positions in research and media institutions. The example presented here is from the Institute for Peace Research in Oslo (PRIO), an institution that historically has had researchers critical of wars of aggression – and which can hardly be labelled friends of nuclear arms.


A researcher is said to seek objectivity and truth.

But he or she learns to select their research topics and arrive at conclusions in accordance with what the authorities and management expect, and this despite the fact that academic freedom is codified in Norway through the “freedom to express oneself publicly”, “freedom to promote new ideas” and “freedom to choose method and material». In today’s societal discourse, freedom of speech seems to be reduced to the right to offend other people’s ethnicity or religion.

But freedom of speech should be about the right to scrutinize power and society. My experience is that the opportunity to express freely as a researcher has become increasingly limited during the last 20 years. How did we end up here?

This is my story as a researcher. For almost 30 years I worked at the Peace Research Institute Oslo (PRIO), from 1987 to 2017. I became a senior researcher after completing my doctorate in 1989 and led the Institute’s program for foreign and security policy. I received my professorship in 2000 and wrote and edited a number of books on international politics and security policy.

After the Libya War in 2011, I wrote a book in Swedish about this war, about how Western bomber aircraft coordinated operations with Islamist rebels and ground forces from Qatar in order to defeat the Libyan army. (I wrote another book on the Libya War in Norwegian, published in 2018.) Western countries were allied with radical Islamists, just as in Afghanistan in the 1980s. In Libya, Islamists carried out ethnic cleansing of black Africans and committed war crimes.

On the other hand, the media claimed that Muammar Gaddafi bombed civilians and planned a genocide in Benghazi.

 » Lees verder

COVID-19, Trust, and Wellcome: How Charity’s Pharma Investments Overlap with Its Research Efforts. BMJ – Global Research

12-03-21 03:32:00,

All Global Research articles can be read in 27 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).


An increasingly clear feature of the covid-19 pandemic is that the public health response is being driven not only by governments and multilateral institutions, such as the World Health Organisation, but also by a welter of public-private partnerships involving drug companies and private foundations.

One leading voice to emerge is the Wellcome Trust, one of the world’s top funders of health research, whose sprawling charitable activities in the pandemic include co-leading a WHO programme to support new covid-19 therapeutics. The Access to Covid-19 Tools (ACT) Accelerator project hopes to raise billions of dollars and deliver hundreds of millions of treatment courses in the year ahead, including dexamethasone and a number of monoclonal antibodies.1

At the same time, The BMJ finds, Wellcome itself holds investments in companies producing these same treatments. Financial disclosures from late 2020 show that Wellcome has a £275m (€318m; $389m) stake in Novartis, which manufactures dexamethasone and is investigating additional therapeutics. And Roche, in which Wellcome holds a £252m stake,2 is helping to manufacture monoclonal antibodies with Regeneron. Both Roche and Novartis report having had conversations with WHO’s ACT Accelerator about their therapeutic drugs.3

Wellcome’s financial interests have been published on the trust’s website and through financial regulatory filings but do not seem to have been disclosed as financial conflicts of interest in the context of Wellcome’s work on covid-19, even as they show that the trust is positioned to potentially gain from the pandemic financially.

Revelations of the Wellcome Trust’s financial conflicts of interest follow news reports that another charity, the Gates Foundation, is also positioned to potentially benefit financially from its leading role in the pandemic response. An investigation by the Nation revealed that Gates had more than $250m (£179m; €206m) invested in companies working on covid-19 and cited civil society groups expressing alarm with the outsize influence the billionaire charity wields in the pandemic response, which they see as elevating the role of the drug industry.4

Yet charities such as Gates and Wellcome—and even drug companies—have generally been praised in the news media during the pandemic for their efforts to solve the public health crisis,

 » Lees verder

Do Your Own Research!

16-10-20 07:54:00,


Dan Williams of interviews James Corbett about the recent Forbes article warning the hoi polloi not to do their own research. They discuss the agenda behind this exhortation and why independent thinkers doing their own research is the bedrock of any truly free society.

Share this:

Vind ik leuk:Like Laden…  » Lees verder

Unprecedented Threat to Independent Media and Freedom on the Internet: Support Global Research! – Global Research

15-09-20 09:06:00,

Dear Readers,

2020 has so far been a year of unprecedented global crises. In an increasingly polarized and crazy world, truly independent news and analysis is a vital weapon for the non-partisan truth, and a tool for prevention from repeating the tragedies of the past. We are currently facing an unprecedented threat to the independent media and freedom on the Internet. The ultimate goal is the silencing of any voice of opposition to the mainstream narrative.

To ensure the longevity of Global Research, we need your help! Our content will always be free, but your donations and membership subscriptions are essential to the functioning of our website. Free content involves some very real costs. We cannot meet these costs without your support. Please click below to make a donation or become a member now.

Click to donate:

Click to make a one-time or a recurring donation

Click to become a member (receive free books!):

Click to view our membership plans

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the
copyright owner.

For media inquiries: [email protected]

 » Lees verder

US Sanctions Russian Research Institute that Developed COVID-19 Vaccine – Global Research

31-08-20 10:21:00,

Russia won the race to develop the first vaccine against the novel coronavirus. The United States has responded by slapping sanctions on a Russian research facility involved in creating it.

The US government has blacklisted several Russian scientific institutes, including the Russian Defense Ministry’s 48th Central Research Institute, which has worked with other non-military medical centers to develop and test the world’s first Covid-19 vaccine.

In the midst of the global coronavirus pandemic and a historic economic crisis, Washington has escalated its global campaign of economic warfare, imposing sanctions on foreign adversaries and announcing new punitive measures on a nearly daily basis.

More than one-fourth of people on Earth live in countries that are suffering from US sanctions.

In April, a Russian company sent ventilators to the United States as a form of humanitarian aid, to help overwhelmed hospitals treat coronavirus patients. It was later revealed that this Russian firm had been under US sanctions since 2014.

State-led Covid-19 vaccine research in Russia, China, Cuba beat US ‘public-private partnership’

The Russian government announced this August that it had registered the world’s first Covid-19 vaccine, called Sputnik V.

Sputnik V was developed by the Russian Health Ministry’s Gamaleya Research Institute of Epidemiology and Microbiology. This scientific facility created the vaccine in a joint research project with the Russian Defense Ministry’s 48th Central Research Institute.

On August 27, the US Commerce Department imposed sanctions on Russia’s 48th Central Research Institute, blacklisting the scientific body.

While Russia took a state-led approach to create a coronavirus vaccine, the Trump administration announced a “public-private partnership” in May. The program, called “Operation Warp Speed,” saw the US government dole out billions of tax dollars to Big Pharma companies.

The Trump administration awarded massive contracts to private corporations like Novavax, Pfizer, and Moderna, while Trump reportedly offered “large sums of money” for exclusive rights to a vaccine being developed by a German firm so it could be sold for profit.

But the US public-private partnership was unable to develop a vaccine before foreign countries with government-led research efforts did.

 » Lees verder